Cell and Gene Therapy Insights

Launched in 2014, Cell & Gene Therapy Insights is our inaugural online, open access, peer-reviewed journal with a translational focus.

Cell & Gene Therapy Insights addresses the important challenges and advances in the field of cell and gene therapy, publishing original research, reviews, commentary articles, clinical trial reports and much more. You can access all of our articles, webinars, podcasts, news...and more...absolutely free.

CELL AND GENE THERAPY INSIGHTS

November 2024

Vol 10 Issue 10

Upcoming webinars

Case study: developing an ex vivo gene-modified hematopoietic stem cell treatment for a rare monogenic disease in a novel mouse model ﻿

Big pharma case study: alpha testing of a generic anti-AAV kit and comparison to in-house methods﻿

Latest Articles

Novel isolation platform with active-release technology for scalable cell therapy manufacturing

A massive thank you to all our Peer Reviewers in 2024

Demystifying AAV affinity capture: mapping AAV affinity ligand footprints with cryo-electron microscopy

Bio-printing in the context of end-to-end scalable tissue-engineered ATMP manufacturing

Navigating the complexities of AAV and lentiviral vector characterization

Balancing precision and efficiency in cell therapy assays: low volume sampling for mycoplasma detection

History and progress in viral vector particle size distribution analysis

Biopharmaceutical Analytics Unveiled: Expert Insights and Customer Success Stories

Preparing for success in gene therapy purification

Channel content

Novel isolation platform with active-release technology for scalable cell therapy manufacturing

Demystifying AAV affinity capture: mapping AAV affinity ligand footprints with cryo-electron microscopy

Bio-printing in the context of end-to-end scalable tissue-engineered ATMP manufacturing

Demystifying AAV affinity capture: mapping AAV affinity ligand footprints with cryo-electron microscopy

Navigating the complexities of AAV and lentiviral vector characterization

History and progress in viral vector particle size distribution analysis

Navigating the complexities of AAV and lentiviral vector characterization

Balancing precision and efficiency in cell therapy assays: low volume sampling for mycoplasma detection

History and progress in viral vector particle size distribution analysis

Shifting to non-viral in vivo therapies to enhance global patient access to genetic medicines

Navigating the European landscape of advanced therapy funding and commercialization

Driving digital innovation for supply chain orchestration in cell and gene therapy

Pioneering quality control in biomanufacturing of cell and gene therapies

Next-generation risk mitigation in the temperature-controlled supply chain for advanced therapies with ISO 21973 compliance

Interpreting the new FDA draft potency guidance: an mRNA gene modified cell therapy perspective

Next-generation risk mitigation in the temperature-controlled supply chain for advanced therapies with ISO 21973 compliance

Operations strategy for a scalable CGT supply chain: key CXO insights

Supply chain sourcing and sustainability strategies for cell therapy and advanced biomaterial products

Looking to a future of multiplex cell engineering

Exploring the burgeoning role of non-viral approaches in the delivery of nucleic acids

Biological & operational considerations for iPSC-derived cell production

Case study: developing an ex vivo gene-modified hematopoietic stem cell treatment for a rare monogenic disease in a novel mouse model

Big pharma case study: alpha testing of a generic anti-AAV kit and comparison to in-house methods